Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:385978.
doi: 10.1155/2012/385978. Epub 2012 Jan 24.

Triple-negative breast cancer: an update on neoadjuvant clinical trials

Affiliations

Triple-negative breast cancer: an update on neoadjuvant clinical trials

Keith D Amos et al. Int J Breast Cancer. 2012.

Abstract

Triple-negative breast cancer (TNBC) is an aggressive malignancy with a poor prognosis despite the high rates of response to chemotherapy. This scenario highlights the need to develop novel therapies and/or treatment strategies to reduce the mortality associated with TNBC. The neoadjuvant setting provides a model for rapid assessment of treatment efficacy with smaller patient accruals and over shorter periods of time compared to the traditional adjuvant setting. In addition, a clear surrogate endpoint of improved survival, known as pathologic complete response, already exists in this setting. Here, we review current data from completed and ongoing neoadjuvant clinical trials for TNBC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical trial design schematic.

Similar articles

Cited by

References

    1. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. Journal of the American Medical Association. 2006;295(21):2492–2502. - PubMed
    1. Koplin LM, O’Connell TX. A new approach to the management of primary unresectable carcinoma of the breast: is radiation therapy necessary? American Journal of Clinical Oncology. 1983;6(5):599–604. - PubMed
    1. Newman LA. Surgical issues and preoperative systemic therapy. Cancer Treatment and Research. 2008;141:79–98. - PubMed
    1. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project B-18. Journal of Clinical Oncology. 1998;16(8):2672–2685. - PubMed
    1. Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. Journal of Clinical Oncology. 2008;26(8):1275–1281. - PubMed

LinkOut - more resources